This seminal paper shows that improved local tumour control in primary tumours leads to decreased metastases and better treatment outcome
Stability and Distribution The molecular architecture enables BPC-157 to remain stable in human gastric juice for over 24 hours and in urine for 4 days, distinguishing it from typical peptides that rapidly degrade
In studies involving patients with both alcoholic and non-alcoholic fatty liver disease, increasing glutathione levels was shown to reduce fat accumulation and significantly improve liver function
Multiple systematic reviews show improvement in pain and function scores compared to hyaluronic acid and placebo injections
Neither compound is approved by Health Canada for therapeutic use, and both are prohibited by the World Anti-Doping Agency
The result is a powerful, multi-ingredient formula that has been clinically researched and proven to support healthy, balanced cytokine function.* Peer-reviewed published clinical research on CytoQuel To demonstrate the efficacy of this formulation, CytoQuel underwent an 8-week clinical human study